Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering
FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation
FSD Pharma Signs LOI to Establish Joint Venture with World-Class Extractions to Deploy Full Extraction Processing Center
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
VanadiumCorp Completes Rock Chip Sampling Program at its Lac Doré Vanadium-Iron-Titanium Project; 53 Samples Submitted to AGAT Laboratories for Analysis
